Federal Register of Legislation - Australian Government

Primary content

PB 93 of 2010 Determinations/Health as amended, taking into account amendments up to National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 1) (PB 10 of 2018)
This instrument determines which Pharmaceutical Benefits Scheme listed drugs are on F1 and which are on F2. This instrument also repeals PB 66 of 2007 and PB 87 of 2007.
Administered by: Health
Registered 01 Feb 2018
Start Date 01 Feb 2018
End Date 31 Mar 2018
Table of contents.

Commonwealth Coat of Arms of Australia

National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010)

made under subsection 85AB(1) of the

National Health Act 1953

Compilation No. 75

Compilation date:                              1 February 2018

Includes amendments up to:            PB 10 of 2018

Registered:                                         1 February 2018

 

About this compilation

This compilation

This is a compilation of the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010) that shows the text of the law as amended and in force on 1 February 2018 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.

Application, saving and transitional provisions for provisions and amendments

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.

Self-repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

  

  

  


Contents

1............ Name of Determination................................................................................................. 1

4............ Definition...................................................................................................................... 1

5............ Drugs on F1.................................................................................................................. 1

6............ Drugs on F2.................................................................................................................. 1

Schedule 1—Drugs on F1                                                                                                                2

Schedule 2—Drugs on F2                                                                                                                8

Endnotes                                                                                                                                                               12

Endnote 1—About the endnotes                                                                                                      12

Endnote 2—Abbreviation key                                                                                                          13

Endnote 3—Legislation history                                                                                                       14

Endnote 4—Amendment history                                                                                                     18


1  Name of Determination

             (1)  This Determination is the National Health (Listed drugs on F1 or F2) Determination 2010.

             (2)  This Determination may also be cited as PB 93 of 2010.

4  Definition

                   In this Determination:

Act means the National Health Act 1953.

5  Drugs on F1

                   For subsection 85AB(1) of the Act, the drugs mentioned in Schedule 1 are on F1.

6  Drugs on F2

                   For subsection 85AB(1) of the Act, the drugs mentioned in Schedule 2 are on F2.


Schedule 1Drugs on F1

(section 5)

  

 


Abacavir

Abciximab

Abiraterone

Acamprosate

Acetazolamide

Aclidinium

Adalimumab

Adapalene with benzoyl peroxide

Adrenaline

Aflibercept

Albendazole

Alectinib

Alemtuzumab

Alogliptin

Amantadine

Ambrisentan

Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine

Amino acid formula with fat, carbohydrate, vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine and supplemented with docosahexaenoic acid

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexanoic acid

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine

Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides

Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine and supplemented with docosahexanoic acid

Amino acid formula with fat, carbohydrate without phenylalanine

Amino acid formula with vitamins and minerals and long chain polyunsaturated fatty acids without phenylalanine

Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid

Amino acid formula with vitamins and minerals without lysine and low in tryptophan

Amino acid formula with vitamins and minerals without methionine

Amino acid formula with vitamins and minerals without methionine, threonine and valine, and low in isoleucine

Amino acid formula with vitamins and minerals without phenylalanine

Amino acid formula with vitamins and minerals without phenylalanine and tyrosine

Amino acid formula with vitamins and minerals without valine, leucine and isoleucine

Amino acid formula without phenylalanine

Amino acid formula without valine, leucine and isoleucine

Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids

Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides

Amino acids—synthetic, formula

Amphotericin

Amylopectin, modified long chain

Anakinra

Apixaban

Apraclonidine

Aprepitant

Arachidonic acid and docosahexaenoic acid with carbohydrate

Arginine with carbohydrate

Armodafinil

Arsenic

Artemether with lumefantrine

Atazanavir

Asenapine

Atovaquone

Atropine

Auranofin

Aurothiomalate

Axitinib

Balsalazide

Bacillus Calmette and Guerin, Tice strain

Beclomethasone

Bendamustine

Benzathine benzylpenicillin

Benzhexol

Benztropine

Benzydamine

Benzylpenicillin

Betaine

Bethanechol

Bevacizumab

Biperiden

Blinatumomab

Bortezomib

Botulinum toxin type A purified neurotoxin complex

Brentuximab vedotin

Brexpiprazole

Budesonide

Buprenorphine

Busulfan

Cabazitaxel

Calcium

Carbimazole

Carbohydrate, fat, vitamins, minerals and trace elements

Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid

Carbomer 974

Carfilzomib

Carmellose

Carmustine

Ceritinib

Certolizumab pegol

Cetrorelix

Cetuximab

Chlorambucil

Chloramphenicol

Chlorpromazine

Chlorthalidone

Cholestyramine

Choriogonadotropin alfa

Ciclesonide

Citrulline

Citrulline with carbohydrate

Cladribine

Clobetasol

Clodronic acid

Clostridium Botulinum Type A Toxin-haemagglutinin Complex

Coal tar

Cobimetinib

Codeine

Corifollitropin alfa

Cortisone

Crizotinib

Cyclophosphamide

Cystine with carbohydrate

Cytarabine

Dabigatran etexilate

Dabrafenib

Daclatasvir

Daclizumab

Dalteparin

Danazol

Dantrolene

Dapagliflozin

Dapsone

Darbepoetin alfa

Darunavir

Dasatinib

Deferasirox

Deferiprone

Degarelix

Denosumab

Desmopressin

Dexamphetamine

Didanosine

Dimethyl fumarate

Diptheria and tetanus vaccine, adsorbed, diluted for adult use

Dipyridamole

Disopyramide

Dolutegravir

Docosahexaenoic acid with carbohydrate

Domperidone

Dornase alfa

Doxepin

Eculizumab

Efavirenz

Eformoterol

Eletriptan

Eltrombopag

Empagliflozin

Emtricitabine

Enfuvirtide

Enoxaparin

Entacapone

Enzalutamide

Epoetin Alfa

Epoetin Beta

Epoetin Lambda

Eptifibatide

Eribulin

Erlotinib

Essential amino acids formula

Essential amino acids formula with minerals and vitamin C

Essential amino acids formula with vitamins and minerals

Ethacrynic acid

Ethosuximide

Etonogestrel

Etravirine

Everolimus

Evolocumab

Exenatide

Ezetimibe

Febuxostat

Fenofibrate

Ferric carboxymaltose

Ferrous fumarate

Ferrous Sulfate

Fingolimod

Fludrocortisone

Fluorometholone

Flupenthixol Decanoate

Fluticasone furoate with vilanterol

Folic acid

Follitropin Beta

Fondaparinux

Fosamprenavir

Fosaprepitant

Fotemustine

Framycetin

Fusidic acid

Ganciclovir

Ganirelix

Gefitinib

Gelatin—succinylated

Glatiramer

Glucagon

Glucose and ketone indicator urine

Glucose indicator—urine

Glycine with carbohydrate

Glycomacropeptide and essential amino acids with vitamins and minerals

Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine

Glycopyrronium

Golimumab

Goserelin

Grazoprevir with elbasvir

Griseofulvin

Haloperidol

Haloperidol decanoate

Heparin

Hexamine

High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate

Human Menopausal Gonadotrophin

Hyaluronic acid

Hydralazine

Hydrochlorothiazide

Hydromorphone

Hydroxyethyl starch 130/0.4

Hydroxyurea

Ibandronic acid

Ibrutinib

Icatibant

Idelalisib

Ifosfamide

Iloprost

IncobotulinumtoxinA

Indacaterol

Indinavir

Insect allergen extract—honey bee venom

Insect allergen extract—paper wasp venom

Insect allergen extract—yellow jacket venom

Insulin aspart

Insulin detemir

Insulin glargine

Insulin glulisine

Insulin isophane

Insulin lispro

Insulin neutral

Interferon alfa‑2a

Interferon alfa‑2b

Interferon beta‑1a

Interferon gamma‑1b

Ipilimumab

Iron sucrose

Isoleucine with carbohydrate

Isoniazid

Ivabradine

Ivacaftor

Ivermectin

Ixekizumab

Ketoconazole

Lacosamide

Lanreotide

Lanthanum

Lapatinib

Lenalidomide

Lenograstim

Lenvatinib

Leuprorelin

Levodopa with benserazide

Levonorgestrel

Lignocaine

Linagliptin

Lincomycin

Liothyronine

Lipegfilgrastim

Lisdexamfetamine

Lithium

Lurasidone

Lutropin alfa

Macitentan

Mannitol

Maraviroc

Magnesium

Mefenamic acid

Melphalan

Mepolizumab

Mercaptopurine

Mesalazine

Mesna

Methoxy polyethylene glycol‑epoetin beta

Methoxyflurane

Methylnaltrexone

Miconazole

Midazolam

Mifepristone and misoprostol

Milk powder—lactose free formula

Milk powder lactose intolerance formula

Milk powder—synthetic

Milk protein and fat formula with vitamins and minerals—carbohydrate free

Minoxidil

Moxonidine

Mupirocin

Nadroparin

Nafarelin

Nandrolone decanoate

Naratriptan

Natalizumab

Nebivolol

Nedocromil

Nicotine

Nintedanib

Nilotinib

Nilutamide

Nitrofurantoin

Nivolumab

Nystatin

Obinutuzumab

Ocrelizumab

Ocriplasmin

Oestriol

Ofatumumab

Ofloxacin

Olaparib

Olsalazine

Oxcarbazepine

Oxprenolol

Oxytocin

Paclitaxel, nanoparticle albumin‑bound

Paliperidone

Palonosetron

Pancreatic extract

Pancrelipase

Panitumumab

Pasireotide

Pazopanib

Peginterferon alfa‑2a

Peginterferon Beta-1a

Pegvisomant

Pembrolizumab

Penicillamine

Perampanel

Perhexiline

Pericyazine

Permethrin

Pertuzumab

Phenelzine

Phenobarbitone

Phenoxybenzamine

Phenylalanine with carbohydrate

Phenytoin

Phytomenadione

Pimecrolimus

Pirfenidone

Pizotifen

Plerixafor

Pneumococcal vaccine, polyvalent

Poly‑L‑Lactic acid

Polyethylene Glycol 400 with Propylene Glycol

Pomalidomide

Ponatinib

Posaconazole

Prasugrel

Praziquantel

Primidone

Probenecid

Procaine penicillin

Progesterone

Promethazine

Propantheline

Propylthiouracil

Protein formula with amino acids, carbohydrates, vitamins and minerals without phenylalanine, and supplemented with docosahexaenoic acid

Protein formula with carbohydrate, fat, vitamins and minerals

Protein hydrolysate formula with medium chain triglycerides

Pyrantel

Pyridostigmine

Pyrimethamine

Quinagolide

Raltegravir

Raltitrexed

Ranibizumab

Rasagiline

Reboxetine

Reteplase

Ribavirin

Rifabutin

Rifampicin

Rifaximin

Rilpivirine

Riociguat

Ritonavir

Rituximab

Rivaroxaban

Romiplostim

Rotigotine

Ruxolitinib

Salcatonin

Salmeterol

Sapropterin

Saquinavir

Saxagliptin

Secukinumab

Sevelamer

Silver sulfadiazine

Sirolimus

Sitagliptin

Sodium acid phosphate

Sodium bicarbonate

Sofosbuvir

Sorafenib

Soy Lecithin

Soy protein and fat formula with vitamins and minerals—carbohydrate free

Stavudine

Sterculia with frangula bark

Sucroferric oxyhydroxide

Sulthiame

Sunitinib

Tadalafil

Tafluprost

Tapentadol

Tenecteplase

Terbutaline

Teriflunomide

Teriparatide

Testosterone

Tetrabenazine

Tetracosactrin

Thalidomide

Theophylline

Thiamine

Thioguanine

Thyrotropin alfa

Tiagabine

Ticagrelor

Tiotropium

Tipranavir

Tocilizumab

Tofacitinib

Toremifene

Trametinib

Tranylcypromine

Trastuzumab

Trastuzumab emtansine

Travoprost

Trifluoperazine

Triglycerides, long chain

Triglycerides, long chain with glucose polymer

Triglycerides, medium chain

Triglycerides, medium chain and long chain with glucose polymer

Triglycerides—medium chain, formula

Triptorelin

Tyrosine with carbohydrate

Umeclidinium

Ustekinumab

Valine with carbohydrate

Varenicline

Vedolizumab

Vemurafenib

Verteporfin

Vigabatrin

Vildagliptin

Vinblastine

Vismodegib

Vitamins, minerals and trace elements formula

Vitamins, minerals and trace elements with carbohydrate

Vorinostat

Warfarin

Whey protein formula supplemented with amino acids, long chain polyunsaturated fatty acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose

Whey protein formula supplemented with amino acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose

Zidovudine

Zuclopenthixol Decanoate

 


Schedule 2Drugs on F2

(section 6)

  

 


Abacavir with Lamivudine

Abatacept

Acarbose

Aciclovir

Acitretin

Adefovir

Alendronic acid

Alendronic acid with colecalciferol

 

Alendronic acid with colecalciferol and calcium

 

Allopurinol

 

Alprazolam

 

Amiodarone

 

Amisulpride

 

Amitriptyline

 

Amlodipine

 

Amlodipine with Atorvastatin

 

Amlodipine with valsartan

 

Amlodipine with valsartan and hydrochlorothiazide

 

Amoxycillin

 

Amoxycillin with clavulanic acid

 

Ampicillin

 

Anastrozole

 

Apomorphine

 

Aripiprazole

 

Aspirin

 

Atenolol

 

Atomoxetine

 

Atorvastatin

 

Azacitidine

 

Azathioprine

 

Azithromycin

 

Baclofen

 

Betamethasone

 

Betaxolol

 

Bicalutamide

 

Bimatoprost

 

Bisacodyl

 

Bisoprolol

 

Bivalirudin

 

Bleomycin

 

Bosentan

 

Brimonidine

 

Brinzolamide

 

Bromocriptine

 

Bupropion

 

Cabergoline

 

Calcipotriol with betamethasone

 

Calcitriol

 

Candesartan

 

Candesartan with Hydrochlorothiazide

 

Capecitabine

 

Captopril

 

Carbamazepine

 

Carbomer

 

Carboplatin

 

Carvedilol

 

Cefaclor

 

Cefalotin

 

Cefepime

 

Cefotaxime

 

Ceftriaxone

 

Cefuroxime

 

Celecoxib

 

Cephalexin

 

Cephazolin

 

Chorionic gonadotrophin

 

Cimetidine

 

Ciprofloxacin

 

Cisplatin

 

Citalopram

 

Clarithromycin

 

Clindamycin

 

Clomiphene

 

Clomipramine

 

Clonazepam

 

Clonidine

 

Clopidogrel

 

Clopidogrel with aspirin

 

Clozapine

 

Codeine with paracetamol

 

Colchicine

 

Cromoglycic acid

 

Cyclosporin

 

Cyproterone

 

Desferrioxamine

 

Desvenlafaxine

 

Dexamethasone

 

Dexamethasone with framycetin and gramicidin

 

Diazepam

 

Diclofenac

 

Dicloxacillin

 

Digoxin

 

Diltiazem

 

Diphenoxylate with atropine

 

Dipyridamole with Aspirin

 

Docetaxel

 

Donepezil

 

Dorzolamide

 

Dorzolamide with timolol

 

Dothiepin

 

Doxorubicin

 

Doxorubicin – Pegylated Liposomal

 

Doxycycline

 

Duloxetine

 

Dutasteride

 

Electrolyte Replacement, Oral

 

Enalapril

 

Enalapril with hydrochlorothiazide

 

Entecavir

 

Epirubicin

 

Eplerenone

 

Epoprostenol

 

Eprosartan

 

Erythromycin

 

Escitalopram

 

Esomeprazole

 

Esomeprazole and clarithromycin and amoxycillin

 

Etanercept

 

Etoposide

 

Exemestane

 

Famciclovir

 

Famotidine

 

Felodipine

 

Fentanyl

 

Filgrastim

 

Flecainide

 

Flucloxacillin

 

Fluconazole

 

Fludarabine

 

Fluorouracil

 

Fluoxetine

 

Flutamide

 

Fluticasone

 

Fluticasone with Salmeterol

 

Fluvastatin

 

Fluvoxamine

 

Folinic acid

 

Follitropin Alfa

 

Fosinopril

 

Fosinopril with hydrochlorothiazide

 

Frusemide

 

Gabapentin

 

Galantamine

 

Gemcitabine

 

Gemfibrozil

 

Gentamicin

 

Glibenclamide

 

Gliclazide

 

Glimepiride

 

Glipizide

 

Glyceryl trinitrate

 

Granisetron

 

Hydrochlorothiazide with amiloride

 

Hydrocortisone

 

Hydroxocobalamin

 

Hydroxychloroquine

 

Hyoscine

 

Hypromellose

 

Hypromellose with carbomer 980

 

Hypromellose with dextran

 

Ibuprofen

 

Idarubicin

 

Imatinib

 

Imipramine

 

Imiquimod

 

Indapamide

 

Indomethacin

 

Infliximab

 

Interferon beta‑1b

 

Ipratropium

 

Irbesartan

 

Irbesartan with Hydrochlorothiazide

 

Irinotecan

 

Iron polymaltose complex

 

Isosorbide dinitrate

 

Isosorbide Mononitrate

 

Isotretinoin

 

Itraconazole

 

Ketoprofen

 

Labetalol

 

Lamivudine

 

Lamivudine with Zidovudine

 

Lamotrigine

 

Lansoprazole

 

Latanoprost

 

Latanoprost with timolol

 

Leflunomide

 

Lercanidipine

 

Letrozole

 

Levetiracetam

 

Levodopa with carbidopa

 

Levonorgestrel with ethinyloestradiol

 

Lisinopril

 

Loperamide

 

Losartan

 

Macrogol 3350

 

Medroxyprogesterone

 

Meloxicam

 

Memantine

 

Metformin

 

Methadone

 

Methotrexate

 

Methyldopa

 

Methylphenidate

 

Methylprednisolone

 

Metoclopramide

 

Metoprolol

 

Metoprolol succinate

 

Metronidazole

 

Mianserin

 

Minocycline

 

Mirtazapine

 

Mitozantrone

 

Moclobemide

 

Modafinil

 

Mometasone

 

Montelukast

 

Morphine

 

Mycophenolic acid

 

Naloxone

 

Naltrexone

 

Naproxen

 

Nevirapine

 

Nicorandil

 

Nifedipine

 

Nitrazepam

 

Nizatidine

 

Norethisterone

 

Norethisterone with ethinyloestradiol

 

Norfloxacin

 

Nortriptyline

 

Octreotide

 

Oestradiol

 

Olanzapine

 

Olmesartan

 

Olmesartan with amlodipine

 

Olmesartan with hydrochlorothiazide

 

Omalizumab

 

Omeprazole

 

Ondansetron

 

Oxaliplatin

 

Oxazepam

 

Oxybutynin

 

Oxycodone

 

Paclitaxel

 

Pamidronic acid

 

Pantoprazole

 

Paracetamol

 

Paraffin

 

Paroxetine

 

Pegfilgrastim

 

Pemetrexed

 

Perindopril

 

Perindopril with amlodipine

 

Perindopril with indapamide

 

Phenoxymethylpenicillin

 

Pilocarpine

 

Pindolol

 

Pioglitazone

 

Piroxicam

 

Polyvinyl alcohol

 

Potassium chloride

 

Potassium chloride with potassium bicarbonate

 

Pramipexole

 

Pravastatin

 

Prazosin

 

Prednisolone

 

Prednisone

 

Pregabalin

 

Prochlorperazine

 

Propranolol

 

Quetiapine

 

Quinapril

 

Quinine

 

Rabeprazole

 

Raloxifene

 

Ramipril

 

Ranitidine

 

Riluzole

 

Risedronic acid

 

Risedronic acid and Calcium

 

Risedronic acid and calcium with colecalciferol

 

Risperidone

 

Rivastigmine

 

Rizatriptan

 

Rosuvastatin

 

Roxithromycin

 

Salbutamol

 

Selegiline

 

Sertraline

 

Sildenafil

 

Simvastatin

 

Somatropin

 

Sorbitol with sodium citrate and sodium lauryl sulfoacetate

 

Sotalol

 

Spironolactone

 

Sucralfate

 

Sulfasalazine

 

Sumatriptan

 

Tacrolimus

 

Tamoxifen

 

Telmisartan

 

Telmisartan with amlodipine

 

Telmisartan with Hydrochlorothiazide

 

Temazepam

 

Temozolomide

 

Tenofovir

 

Tenofovir with emtricitabine

 

Terbinafine

 

Thyroxine

 

Timolol

 

Tinidazole

 

Tirofiban

 

Tobramycin

 

Topiramate

 

Topotecan

 

Tramadol

 

Trandolapril

 

Tranexamic acid

 

Triamcinolone

 

Triamcinolone with neomycin, gramicidin and nystatin

 

Trimethoprim

 

Trimethoprim with sulfamethoxazole

 

Tropisetron

 

Ursodeoxycholic acid

 

Valaciclovir

 

Valganciclovir

 

Valproic acid

 

Valsartan

 

Valsartan with hydrochlorothiazide

 

Vancomycin

 

Venlafaxine

 

Verapamil

 

Vincristine

 

Vinorelbine

 

Voriconazole

 

Ziprasidone

 

Zoledronic acid

 

Zolmitriptan

 

Zonisamide

 


 


Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.

If a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.

 

Endnote 2—Abbreviation key

 

ad = added or inserted

o = order(s)

am = amended

Ord = Ordinance

amdt = amendment

orig = original

c = clause(s)

par = paragraph(s)/subparagraph(s)

C[x] = Compilation No. x

    /sub‑subparagraph(s)

Ch = Chapter(s)

pres = present

def = definition(s)

prev = previous

Dict = Dictionary

(prev…) = previously

disallowed = disallowed by Parliament

Pt = Part(s)

Div = Division(s)

r = regulation(s)/rule(s)

ed = editorial change

reloc = relocated

exp = expires/expired or ceases/ceased to have

renum = renumbered

    effect

rep = repealed

F = Federal Register of Legislation

rs = repealed and substituted

gaz = gazette

s = section(s)/subsection(s)

LA = Legislation Act 2003

Sch = Schedule(s)

LIA = Legislative Instruments Act 2003

Sdiv = Subdivision(s)

(md) = misdescribed amendment can be given

SLI = Select Legislative Instrument

    effect

SR = Statutory Rules

(md not incorp) = misdescribed amendment

Sub‑Ch = Sub‑Chapter(s)

    cannot be given effect

SubPt = Subpart(s)

mod = modified/modification

underlining = whole or part not

No. = Number(s)

    commenced or to be commenced

 

Endnote 3—Legislation history

 

Name

Registration

Commencement

Application, saving and transitional provisions

PB 93 of 2010

8 Oct 2010
(F2010L02642)

11 Oct 2010

 

PB 107 of 2010

29 Oct 2010 (F2010L02863)

1 Nov 2010

PB 112 of 2010

30 Nov 2010 (F2010L03131)

1 Dec 2010

PB 9 of 2011

31 Jan 2011 (F2011L00167)

1 Feb 2011

s 1(1) as am. by PB 19 of 2011

as amended by

 

 

 

PB 19 of 2011

31 Jan 2011 (F2011L00172)

1 Feb 2011

PB 20 of 2011

28 Feb 2011 (F2011L00323)

1 Mar 2011

PB 27 of 2011

31 Mar 2011 (F2011L00544)

1 Apr 2011

PB 33 of 2011

20 Apr 2011 (F2011L00623)

1 May 2011

PB 40 of 2011

25 May 2011 (F2011L00859)

1 June 2011

PB 44 of 2011

17 June 2011 (F2011L01065)

1 July 2011

PB 51 of 2011

29 July 2011 (F2011L01557)

1 Aug 2011

PB 60 of 2011

30 Aug 2011 (F2011L01772)

1 Sept 2011

PB 71 of 2011

29 Sept 2011 (F2011L01994)

1 Oct 2011

PB 77 of 2011

26 Oct 2011 (F2011L02133)

1 Nov 2011

PB 90 of 2011

29 Nov 2011 (F2011L02495)

1 Dec 2011

PB 98 of 2011

15 Dec 2011 (F2011L02699)

1 Jan 2012

PB 10 of 2012

21 Feb 2012 (F2012L00346)

1 Mar 2012

PB 17 of 2012

30 Mar 2012 (F2012L00727)

1 Apr 2012

PB 30 of 2012

24 May 2012 (F2012L01074)

1 June 2012

PB 41 of 2012

15 June 2012 (F2012L01208)

1 July 2012

PB 53 of 2012

30 July 2012 (F2012L01621)

1 Aug 2012

PB 67 of 2012

21 Aug 2012 (F2012L01716)

1 Sept 2012

PB 81 of 2012

26 Sept 2012 (F2012L01938)

1 Oct 2012

PB 99 of 2012

29 Nov 2012 (F2012L02282)

1 Dec 2012

PB 12 of 2013

27 Feb 2013 (F2013L00329)

1 Mar 2013

PB 19 of 2013

28 Mar 2013 (F2013L00575)

1 Apr 2013

PB 46 of 2013

29 July 2013 (F2013L01454)

1 Aug 2013

PB 58 of 2013

16 Aug 2013 (F2013L01585)

1 Sept 2013

PB 68 of 2013

18 Sept 2013 (F2013L01707)

1 Oct 2013

PB 73 of 2013

16 Oct 2013 (F2013L01800)

1 Nov 2013

PB 76 of 2013

29 Nov 2013 (F2013L02008)

1 Dec 2013

PB 15 of 2014

21 Feb 2014 (F2014L00171)

1 Mar 2014

PB 22 of 2014

27 Mar 2014 (F2014L00358)

1 Apr 2014

PB 32 of 2014

15 Apr 2014 (F2014L00413)

1 May 2014

PB 43 of 2014

21 May 2014 (F2014L00580)

1 June 2014

PB 47 of 2014

19 June 2014 (F2014L00762)

1 July 2014

PB 54 of 2014

30 July 2014
(F2014L01051)

1 Aug 2014

PB 66 of 2014

7 Aug 2014
(F2014L01075)

8 Aug 2014

PB 70 of 2014

29 Aug 2014
(F2014L01171)

1 Sept 2014

PB 76 of 2014

30 Sept 2014 (F2014L01171)

1 Oct 2014

PB 85 of 2014

30 Oct 2014 (F2014L01440)

1 Nov 2014 (s 2)

PB 95 of 2014

1 Dec 2014 (F2014L01609)

1 Dec 2014 (s 2)

PB 105 of 2014

23 Dec 2014 (F2014L01808)

1 Jan 2015 (s 2)

PB 6 of 2015

29 Jan 2015 (F2015L00082)

1 Feb 2015 (s 2)

PB 15 of 2015

27 Feb 2015 (F2015L00222)

1 Mar 2015 (s 2)

PB 35 of 2015

30 Mar 2015 (F2015L00377)

1 Apr 2015 (s 2)

PB 52 of 2015

29 May 2015 (F2015L00755)

1 June 2015 (s 2)

PB 61 of 2015

1 July 2015
(F2015L01081)

1 July 2015 (s 2)

PB 75 of 2015

31 July 2015 (F2015L01208)

1 Aug 2015 (s 2)

PB 82 of 2015

31 Aug 2015 (F2015L01360)

1 Sept 2015 (s 2)

PB 98 of 2015

1 Oct 2015  (F2015L01599)

1 Oct 2015 (s 2)

PB 106 of 2015

29 Oct 2015 (F2015L01717)

1 Nov 2015 (s 2)

PB 113 of 2015

1 Dec 2015 (F2015L01902)

1 Dec 2015 (s 2)

PB 123 of 2015

24 Dec 2015 (F2015L02136)

1 Jan 2016 (s 2)

PB 7 of 2016

1 Feb 2016 (F2016L00082)

1 Feb 2016 (s 2)

PB 16 of 2016

29 Feb 2016 (F2016L00185)

1 Mar 2016 (s 2)

PB 26 of 2016

1 Apr 2016 (F2016L00468)

1 Apr 2016 (s 2)

PB 37 of 2016

29 Apr 2016 (F2016L00608)

1 May 2016 (s 2)

PB 48 of 2016

31 May 2016 (F2016L00864)

1 June 2016 (s 2)

PB 57 of 2016

23 June 2016 (F2016L01068)

1 July 2016 (s 2)

PB 70 of 2016

28 July 2016 (F2016L01243)

1 Aug 2016 (s 2)

PB 78 of 2016

26 Aug 2016 (F2016L01336)

1 Sept 2016 (s 2)

PB 88 of 2016

29 Sept 2016 (F2016L01546)

1 Oct 2016 (s 2)

PB 95 of 2016

28 Oct 2016 (F2016L01650)

1 Nov 2016 (s 2)

as amended by

 

 

 

PB 96 of 2016

31 Oct 2016 (F2016L01690)

11.59 pm 31 Oct 2016 (s 2)

PB 104 of 2016

30 Nov 2016 (F2016L01833)

1 Dec 2016 (s 2)

PB 112 of 2016

22 Dec 2016 (F2016L02033)

1 Jan 2017 (s 2)

PB 9 of 2017

27 Jan 2017 (F2017L00076)

1 Feb 2017 (s 2)

PB 22 of 2017

30 Mar 2017 (F2017L00361)

1 Apr 2017 (s 2)

PB 32 of 2017

28 Apr 2017 (F2017L00486)

1 May 2017 (s 2)

PB 41 of 2017

31 May 2017 (F2017L00623)

1 June 2017 (s 2)

PB 49 of 2017

29 June 2017 (F2017L00819)

1 July 2017 (s 2)

PB 60 of 2017

28 July 2017 (F2017L00970)

1 Aug 2017 (s 2)

PB 68 of 2017

30 Aug 2017 (F2017L01110)

1 Sept 2017 (s 2)

PB 79 of 2017

29 Sept 2017 (F2017L01304)

1 Oct 2017 (s 2)

PB 97 of 2017

29 Nov 2017 (F2017L01544)

1 Dec 2017 (s 2)

PB 106 of 2017

18 Dec 2017 (F2017L01630)

1 Jan 2018 (s 2)

PB 10 of 2018

31 Jan 2018 (F2018L00071)

1 Feb 2018 (s 2)

 

Endnote 4—Amendment history

 

Provision affected

How affected

s 2.............................................

rep LA s 48D

s 3.............................................

rep LA s 48C

Schedule 1

 

Schedule 1................................

am PB 107 and 112 of 2010; PB 9, 20, 27, 33, 40, 44, 51, 60, 77, 90 and 98 of 2011; PB 10, 17, 41, 53, 67, 81 and 99 of 2012; PB 12, 19, 46, 58, 68, 73 and 76 of 2013; PB 15, 22, 32, 43, 47, 54, 66, 70, 76, 85, 95 and 105 of 2014; PB 6, 15, 35, 52, 61, 75, 82, 98, 106, 113 and 123 of 2015; PB 7, 16, 26, 37, 48, 57, 70, 78, 88 (Sch 1 item 2 md), 95 (as am by PB 96 of 2016), 104 and 112 of 2016; PB 9 of 2017; PB 22 of 2017; PB 32 of 2017; PB 41 of 2017; PB 49 of 2017; PB 60 of 2017; PB 68 of 2017; PB 79 of 2017; PB 97 of 2017; PB 106 of 2017; PB 10 of 2018

Schedule 2

 

Schedule 2................................

am PB 112 of 2010; PB 9, 20, 27, 44, 51, 71 and 90 of 2011; PB 17, 30, 53, 81 and 99 of 2012; PB 19, 46, 68 and 76 of 2013; PB 22, 47, 54, 66, 70 and 95 2014; PB 6, 35, 75, 82, 113 and 123 of 2015; PB 7, 26, 37, 48, 70, 88 and 104 of 2016; PB 9 of 2017 (Sch 1 item 5 md not incorp); PB 22 of 2017; PB 32 of 2017; PB 41 of 2017; PB 49 of 2017; PB 60 of 2017; PB 79 of 2017; PB 97 of 2017; PB 10 of 2018